REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 133 filers reported holding REVANCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $1,083,187 | +0.7% | 220,160 | +79.8% | 0.21% | +0.9% |
Q4 2023 | $1,076,063 | +12.0% | 122,419 | +46.2% | 0.21% | +35.0% |
Q3 2023 | $960,590 | -65.1% | 83,748 | -23.1% | 0.16% | -59.2% |
Q2 2023 | $2,755,247 | -21.2% | 108,860 | +0.2% | 0.38% | -24.2% |
Q1 2023 | $3,498,425 | +278881.3% | 108,613 | +59.9% | 0.51% | +160.5% |
Q4 2022 | $1,254 | -99.9% | 67,933 | -1.0% | 0.20% | -34.1% |
Q3 2022 | $1,853,000 | +110.8% | 68,622 | +7.9% | 0.30% | +108.5% |
Q2 2022 | $879,000 | -30.1% | 63,588 | -1.4% | 0.14% | -9.6% |
Q1 2022 | $1,258,000 | -40.4% | 64,509 | -50.1% | 0.16% | -35.1% |
Q4 2021 | $2,112,000 | -42.3% | 129,384 | -1.5% | 0.24% | -46.1% |
Q3 2021 | $3,659,000 | -6.0% | 131,325 | 0.0% | 0.45% | -0.9% |
Q2 2021 | $3,892,000 | +0.2% | 131,325 | -5.5% | 0.45% | -4.4% |
Q1 2021 | $3,885,000 | +78.8% | 138,989 | +81.3% | 0.47% | +75.6% |
Q4 2020 | $2,173,000 | -13.6% | 76,671 | -23.3% | 0.27% | -25.0% |
Q3 2020 | $2,514,000 | +53.4% | 100,000 | +49.0% | 0.36% | +33.8% |
Q2 2020 | $1,639,000 | +10.7% | 67,102 | -32.9% | 0.27% | -10.3% |
Q1 2020 | $1,480,000 | -31.8% | 100,000 | +14.5% | 0.30% | +17.6% |
Q3 2018 | $2,171,000 | -9.5% | 87,355 | 0.0% | 0.26% | -15.0% |
Q2 2018 | $2,398,000 | -30.1% | 87,355 | -21.6% | 0.30% | -33.5% |
Q1 2018 | $3,430,000 | -19.4% | 111,360 | -6.4% | 0.45% | -19.6% |
Q4 2017 | $4,253,000 | +47.1% | 118,952 | +13.4% | 0.56% | +42.7% |
Q3 2017 | $2,891,000 | -12.3% | 104,928 | -16.0% | 0.39% | -16.7% |
Q2 2017 | $3,298,000 | +60.6% | 124,932 | +26.6% | 0.47% | +46.6% |
Q1 2017 | $2,053,000 | +8.7% | 98,684 | +8.2% | 0.32% | +3.5% |
Q4 2016 | $1,888,000 | +35.4% | 91,228 | +6.1% | 0.31% | +38.2% |
Q3 2016 | $1,394,000 | +25.5% | 86,000 | +5.3% | 0.22% | +21.6% |
Q2 2016 | $1,111,000 | -22.1% | 81,701 | 0.0% | 0.18% | -24.2% |
Q1 2016 | $1,426,000 | -41.8% | 81,701 | +13.9% | 0.24% | -36.3% |
Q4 2015 | $2,449,000 | +14.8% | 71,701 | 0.0% | 0.38% | +9.4% |
Q3 2015 | $2,134,000 | -6.9% | 71,701 | 0.0% | 0.35% | +1.2% |
Q2 2015 | $2,293,000 | – | 71,701 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NQ HCIF GP, Ltd. | 3,096,650 | $52,457,000 | 100.00% |
Essex Woodlands Management, Inc. | 4,592,047 | $77,789,000 | 24.28% |
Rhenman & Partners Asset Management AB | 126,574 | $2,144,000 | 0.62% |
Polar Capital LLP | 1,107,272 | $18,756,000 | 0.37% |
ArrowMark Colorado Holdings LLC | 787,923 | $13,347,000 | 0.34% |
Lombard Odier Asset Management (USA) Corp | 250,605 | $4,245,000 | 0.29% |
Visium Asset Management, LP | 1,000,000 | $16,940,000 | 0.24% |
C Partners Holding GmbH | 24,000 | $407,000 | 0.13% |
NOTTINGHAM ADVISORS, INC. | 23,018 | $390,000 | 0.10% |
WALL STREET ASSOCIATES | 57,330 | $971,000 | 0.09% |